Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer.

Karakas C, Francis AM, Ha MJ, Wingate HF, Meena RA, Yi M, Rasaputra KS, Barrera AMG, Arun B, Do KA, Sahin A, Keyomarsi K, Hunt KK.

Ann Surg. 2019 Aug 20. doi: 10.1097/SLA.0000000000003551. [Epub ahead of print]

PMID:
31436549
2.

In vitro cytotoxic activity of microalgal extracts loaded nano-micro particles produced via electrospraying and microemulsion methods.

Karakaş CY, Tekarslan Şahin H, İnan B, Özçimen D, Erginer YÖ.

Biotechnol Prog. 2019 Jun 25:e2876. doi: 10.1002/btpr.2876. [Epub ahead of print]

PMID:
31237985
3.

Dedifferentiated gastrointestinal stromal tumor: Recent advances.

Karakas C, Christensen P, Baek D, Jung M, Ro JY.

Ann Diagn Pathol. 2019 Apr;39:118-124. doi: 10.1016/j.anndiagpath.2018.12.005. Epub 2018 Dec 18. Review.

PMID:
30661742
4.

Metabolomics of mammalian brain reveals regional differences.

Choi WT, Tosun M, Jeong HH, Karakas C, Semerci F, Liu Z, Maletić-Savatić M.

BMC Syst Biol. 2018 Dec 21;12(Suppl 8):127. doi: 10.1186/s12918-018-0644-0.

5.

A child with antibody-negative immune-mediated necrotizing myopathy.

Karakas C, Sah J, Seidman R, Chari G, Hisamoto Y, Cracco J, Reznikov A, Giridharan R, Anziska Y.

Muscle Nerve. 2019 Feb;59(2):E10-E13. doi: 10.1002/mus.26375. Epub 2018 Nov 28. No abstract available.

PMID:
30390296
6.

Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition.

Chen X, Low KH, Alexander A, Jiang Y, Karakas C, Hess KR, Carey JPW, Bui TN, Vijayaraghavan S, Evans KW, Yi M, Ellis DC, Cheung KL, Ellis IO, Fu S, Meric-Bernstam F, Hunt KK, Keyomarsi K.

Clin Cancer Res. 2018 Dec 15;24(24):6594-6610. doi: 10.1158/1078-0432.CCR-18-1446. Epub 2018 Sep 4.

PMID:
30181387
7.

Molecular mechanisms involving prostate cancer racial disparity.

Karakas C, Wang C, Deng F, Huang H, Wang D, Lee P.

Am J Clin Exp Urol. 2017 Nov 9;5(3):34-48. eCollection 2017. Review.

8.

Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer.

Carey JPW, Karakas C, Bui T, Chen X, Vijayaraghavan S, Zhao Y, Wang J, Mikule K, Litton JK, Hunt KK, Keyomarsi K.

Cancer Res. 2018 Feb 1;78(3):742-757. doi: 10.1158/0008-5472.CAN-17-1494. Epub 2017 Nov 27.

9.

Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer.

Doostan I, Karakas C, Kohansal M, Low KH, Ellis MJ, Olson JA Jr, Suman VJ, Hunt KK, Moulder SL, Keyomarsi K.

Clin Cancer Res. 2017 Dec 1;23(23):7288-7300. doi: 10.1158/1078-0432.CCR-17-1544. Epub 2017 Sep 25.

10.

CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers.

Vijayaraghavan S, Karakas C, Doostan I, Chen X, Bui T, Yi M, Raghavendra AS, Zhao Y, Bashour SI, Ibrahim NK, Karuturi M, Wang J, Winkler JD, Amaravadi RK, Hunt KK, Tripathy D, Keyomarsi K.

Nat Commun. 2017 Jun 27;8:15916. doi: 10.1038/ncomms15916.

11.

Adaptive self-organization of Bali's ancient rice terraces.

Lansing JS, Thurner S, Chung NN, Coudurier-Curveur A, Karakaş Ç, Fesenmyer KA, Chew LY.

Proc Natl Acad Sci U S A. 2017 Jun 20;114(25):6504-6509. doi: 10.1073/pnas.1605369114. Epub 2017 Jun 5.

12.

Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer.

Alexander A, Karakas C, Chen X, Carey JP, Yi M, Bondy M, Thompson P, Cheung KL, Ellis IO, Gong Y, Krishnamurthy S, Alvarez RH, Ueno NT, Hunt KK, Keyomarsi K.

Oncotarget. 2017 Feb 28;8(9):14897-14911. doi: 10.18632/oncotarget.14689.

13.

Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer.

Hunt KK, Karakas C, Ha MJ, Biernacka A, Yi M, Sahin AA, Adjapong O, Hortobagyi GN, Bondy M, Thompson P, Cheung KL, Ellis IO, Bacus S, Symmans WF, Do KA, Keyomarsi K.

Clin Cancer Res. 2017 Jun 15;23(12):2991-3002. doi: 10.1158/1078-0432.CCR-16-2217. Epub 2016 Nov 23.

14.

Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer.

Karakas C, Biernacka A, Bui T, Sahin AA, Yi M, Akli S, Schafer J, Alexander A, Adjapong O, Hunt KK, Keyomarsi K.

Am J Pathol. 2016 Jul;186(7):1900-1912. doi: 10.1016/j.ajpath.2016.02.024. Epub 2016 May 13.

15.

Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells.

Lucenay KS, Doostan I, Karakas C, Bui T, Ding Z, Mills GB, Hunt KK, Keyomarsi K.

Cancer Res. 2016 Apr 15;76(8):2406-18. doi: 10.1158/0008-5472.CAN-15-1646. Epub 2016 Feb 29.

17.

PKCiota promotes ovarian tumor progression through deregulation of cyclin E.

Nanos-Webb A, Bui T, Karakas C, Zhang D, Carey JP, Mills GB, Hunt KK, Keyomarsi K.

Oncogene. 2016 May 12;35(19):2428-40. doi: 10.1038/onc.2015.301. Epub 2015 Aug 17.

18.

Erratum to: Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.

Caruso JA, Karakas C, Zhang J, Yi M, Albarracin C, Sahin A, Bondy M, Liu J, Hunt KK, Keyomarsi K.

Breast Cancer Res. 2015 Jun 25;17:87. doi: 10.1186/s13058-015-0572-5. No abstract available.

19.

A phase 1 study with dose expansion of the CDK inhibitor dinaciclib (SCH 727965) in combination with epirubicin in patients with metastatic triple negative breast cancer.

Mitri Z, Karakas C, Wei C, Briones B, Simmons H, Ibrahim N, Alvarez R, Murray JL, Keyomarsi K, Moulder S.

Invest New Drugs. 2015 Aug;33(4):890-4. doi: 10.1007/s10637-015-0244-4. Epub 2015 May 7.

PMID:
25947565
20.

Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.

Caruso JA, Karakas C, Zhang J, Yi M, Albarracin C, Sahin A, Bondy M, Liu J, Hunt KK, Keyomarsi K.

Breast Cancer Res. 2014;16(6):3417. Erratum in: Breast Cancer Res. 2015;17:87.

21.

Inferring metabolic networks using the Bayesian adaptive graphical lasso with informative priors.

Peterson C, Vannucci M, Karakas C, Choi W, Ma L, Maletić-Savatić M.

Stat Interface. 2013 Oct 1;6(4):547-558.

22.

Paget's disease of the breast.

Karakas C.

J Carcinog. 2011;10:31. doi: 10.4103/1477-3163.90676. Epub 2011 Dec 8.

23.

Hyperthyroidism as a rare cause of complete AV block.

Karakaş CY, Topaloğlu C, Canbolant E, Seyfeli E, Akgül F.

Anadolu Kardiyol Derg. 2009 Feb;9(1):67-8. No abstract available.

24.

Quantitative assessment of HER-2/neu protein concentration in breast cancer by enzyme-linked immunosorbent assay.

Müller V, Thomssen C, Karakas C, Eustermann I, Ramirez Porras J, Coith C, Berger J, Löning T, Jänicke F, Pantel K.

Int J Biol Markers. 2003 Jan-Mar;18(1):13-20.

PMID:
12699058

Supplemental Content

Loading ...
Support Center